Function and indications
This product is suitable for newborns and infants who are about to enter or born in the first respiratory syncytial virus (RSV) infection season to prevent RSV-induced lower respiratory tract infections.
Nicevir is a recombinant human IgG1K monoclonal antibody that provides passive immunity by targeting the prefusion conformation of the respiratory syncytial virus (RSV) F protein.
Combination medication
Reasonable drug combination can enhance efficacy or reduce adverse drug reactions, otherwise it can lead to reduced efficacy or increased toxicity, and some abnormal reactions may occur, interfere with treatment, and aggravate the condition. Therefore, when patients take the medicine, do not use it in combination with other drugs privately to avoid drug interactions. If you want to use it with other drugs at the same time, please consult a doctor or pharmacist before use.
Let us work together to protect precious health